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ABSTRACT
Objective: The present study was focused to design an herbal formulation for the treatment of Alzheimer’s disease (AD) to develop the formulation 
using various techniques such as spray drying, centrifugation, and lyophilization and to conduct behavioral studies to evaluate the activity of the 
herbal formulation.
Methods: Formulation contains herbal extracts such as curcumin, guggul, and ashwagandha. To develop this formulation, various techniques such 
as spray drying, centrifugation, and lyophilization were employed along with a natural polymer chitosan in various combinations of excipient. 
Preformulation studies such as solubility of herbal extracts and Fourier transmission infrared spectroscopy (FT-IR) studies for compatibility of the 
natural polymer with herbal extracts were studied. The formulation was characterized by tests such as particle size determination using optical 
microscopy, surface morphological evaluation using scanning electron microscopy (SEM), and behavioral testing by Morris water maze test using 
diazepam-induced amnesia method.
Results: The particle size varied from 12.27 µ for normal chitosan to 3.59 µ for spray-dried chitosan. In the same way, the particle of normal formulation 
(12.9 µ) was about 4–5 times larger than that of spray-dried formulation (2.7 µ). The SEM images showed no proper morphology for chitosan, round 
surface with wrinkles for spray-dried chitosan, improper structures for normal formulation, and rounded smooth surface for spray-dried formulation. 
Significant p value was shown when the spray-dried test formulation was tested using diazepam-induced amnesia method. The transfer latency was 
noted on the 8th day and after 24 h of intraperitoneal administration of diazepam for the test group.
Conclusion: In the present research study, an attempt was made to design and develop a novel drug delivery system using herbal medicine to treat 
AD. FT-IR compatibility study was carried out using the selected polymer and the herbal extracts using novel spray-drying techniques; behavioral 
studies were also done.
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INTRODUCTION
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder 
that slowly destroys memory and thinking skills and eventually the 
ability to carry out the simplest tasks [1]. Loss of cognitive ability with 
age is considered to be a normal process whose rate and extent are very 
variable. AD was originally defined as presenile dementia, but now, it 
appears to be the same pathology underlies the dementia irrespective 
of the age of onset. Its prevalence rises sharply with age, from about 
5% at 65–90% or more at 95 [2]. AD is associated with brain shrinkage 
and localized loss of neurons, mainly in the hippocampus and basal 
forebrain. The loss of cholinergic neurons in the hippocampus and 
frontal cortex is a feature of the disease and is thought to underlie the 
cognitive deficit and loss of short-term memory that occurs in AD.
Among the 120 active compounds currently isolated from the higher 
plants and widely used in modern medicine today, 80% show a positive 
correlation between their modern therapeutic use and the traditional 
use of the plants from which they are derived [3]. According to the 
survey, herbal therapy is said to be the most potential alternative to treat 
AD with minimal side effects. Risk-to-benefit ratio is also convincing as 
any overdosage of these phytoconstituents is not deleterious and these 
can be used as nutraceuticals too so that they can treat any unaddressed 
diseases or disorders.
Herbal constituents possess anti-inflammatory activity which helps in 
reducing inflammation in brain tissue of AD patient. Acetylcholine is 
the main neurotransmitter responsible for cognitive impairment. Any 
herbs that can elevate these levels can be used for treating AD. Ayurvedic 
plants such as Curcuma longa, Withania somnifera, Commiphora mukul, 
Ginseng, and Brahmi. Advantages of herbal medicine include reduced 
risk of side effects, effectiveness with chronic conditions, lower cost, 
and wide spread availability [4].
The present research was done using polyherbal extracts. To 
formulate this, a novel technique called spray drying was used to 
prepare the formulation. While formulating, preformulation studies 
were performed to formulation, surface morphology of was studied; 
additionally, behavioral studies were also conducted.
Spray-drying technique is a technique to generate powders by 
transforming the feed from a liquid state into a dried particulate 
form, by spraying the feed into a hot drying medium. The feed can be 
a solution, suspension, dispersion, or an emulsion. The solution to be 
dried is sprayed into a hot air stream and circulated through a chamber. 
The dried product may be carried out to cyclone or bag separators or 
may fall to the bottom of the drying chamber and be expelled through 
a valve.
Spray-drying process consists of various steps:
1. Atomization.
2. Spray-hot air contact.
3. Evaporation.
4. Separation.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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MATERIALS AND METHODS
Animals, chemicals, and reagents
Sprague Dawley (SD) rats of either sex, herbal extracts (C. longa, 
W. somnifera, and C. mukul) were obtained as a gift sample from 
Sunpure Extracts Pvt., Ltd., Delhi, and chitosan from Indian seafoods, 
glutaraldehyde, acetone, ethyl acetate, liquid paraffin, Span 80, Tween 
80, sodium sulfate, lactose, glacial acetic acid, diazepam, and donepezil. 
All the chemicals and reagents used were of analytical grade.
Instruments
Spray dryer (CRONIMACH), centrifuge (REMI), Fourier transmission 
infrared spectroscopy (FT-IR) (BRUKER), optical microscope 
(OLYMPUS), scanning electron microscopy (SEM) (NIKON TS 100), 
magnetic stirrer (REMI), mechanical stirrer (REMI), ultra probe 
sonicator (OSCAR), Ultra-Turrax (IKA T25), freeze dryer (iLShin), and 
weighing balance (SHIMADZU) were used.
EXPERIMENTAL METHODOLOGY
Compatibility studies
FT-IR study was carried out using FT-IR (BRUKER), where the spectra of 
chitosan, herbal extracts, spray-dried chitosan, the physical mixtures of 
herbal extracts with chitosan, the physical mixtures of herbal extracts 
with spray-dried chitosan, and for the final spray-dried formulation 
were taken for the study.
Design of formulation
Drug delivery system containing herbal extracts was developed by the 
following methods.
By cross-linking and centrifugation technique
Chitosan solution of the concentration of 2 µg/ml was prepared using 
1% acetic acid and stirred for 24 h. To this polymer solution, sodium 
sulfate was added to separate out the particles. After stirring for 1 h, 
glutaraldehyde was added to cross-link the polymer. To this solution, 
extracts were added 100 µg each by dissolving in ethyl acetate. The formed 
solution was stirred using Ultra-Turrax for 5 min at 2800–3000 rpm and 
centrifuged. The solid portion was collected, dispersed in deionized 
water, and kept for freeze drying at – 47°C for 72–96 h.
By spray-drying technique
Chitosan solution of the concentration of 2 µg/ml was prepared using 
1% acetic acid and stirred for 24 h. All the three extracts were weighed 
100 µg each and dissolved in ethyl acetate. This solution containing 
herbal extracts was added to previously prepared chitosan solution. 
The formed solution was stirred using Ultra-Turrax for 5 min at 
2800–3000 rpm. The resultant solution was spray dried by employing 
inlet air temperature of 120°C and a pressure of 1–1.5 psig [Fig. 1] [6-10].
Evaluation
Measurement of particle size
The particle sizes of all the formulations were determined using 
Olympus CX 21i Biological Microscope. The formulations were placed 
on the glass slide and made it to suspend using glycerin-water and 
placed with coverslip over the preparation and measured. The images 
were taken using the microscope, and the particle size was determined 
to obtain average minimum radius and average maximum radius.
Fig. 1: Process steps of spray drying. (1) Atomization, (2) Spray-hot air contact, (3) Evaporation, (4) Separation [5]
Fig. 2: FT-IR Spectrum of chitosan
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Fig. 3: FT-IR Spectrum of spray dried chitosan
Fig. 4: FT-IR spectrum of curcumin extract
Fig. 5: FT-IR spectrum ofmixture of curcumin extract with chitosan
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Fig. 6: FT-IR spectrum of curcumin extract with spray dried chitosan
Fig. 7: FT-IR spectrum of Commiphora mukul extact
Fig. 8:  FT-IR Spectrum Commiphora mukul extract with chitosan
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Fig. 9: FT-IR Spectrum of Commiphora mukul extract with spray-dried chitosan
Fig. 10: FT-IR spectrum of Withania somnifera extract
Surface morphology
The surface morphology of the formulations was determined by SEM 
using NIKON TS100 Eclipse. The powders were fixed on a brass stub 
using double-sided adhesive tape and then were made electrically 
conductive by coating, in a vacuum with a thin layer of platinum 
(approximately 3–5 nm), for 100 S and at 30 W. Images were taken at 
an excitation voltage of 10 kV and a magnification of 5 or 15 k.
In vivo studies
SD rats of either sex (200–300 g) were maintained for 7 days in the 
animal house of Chalapathi Institute of Pharmaceutical Sciences, Guntur, 
under standard conditions temperature (24±10°C), relative humidity 
(45–55%), and 12:12 light:dark cycle. The animals were fed with 
standard rat pellet and water. The animals were allowed to acclimatize 
to laboratory conditions 48 h before the start of the experiment. Each 
group contains five animals.
Ethical approval
All the protocols were approved by the Institutional Animal Ethical 
Committee (IAEC) and conducted according to Committee for the 
Purpose of Control and Supervision of Experimental Animals (CPCSEA) 
registered no: 1048/PO/Re/S/07/CPCSEA at the Department of 
Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Guntur.
Experimental design
The learning and memory enhancing activity of the test formulation 
was investigated. Diazepam was used to induce amnesia like condition 
in the dose of 1 µg/kg administered intraperitoneal for 8 days. The test 
animals were randomly chosen and divided into three groups having 
five rats in each as follows:
•	 Group	 I:	 Inducing	group	–	diazepam	(1	µg/kg	was	administered	
intraperitoneal for 8 days).
•	 Group	II:	Standard	group	–	donepezil	hydrochloride	(2.5	µg/kg	was	
administered orally for 8 days).
•	 Group	 III:	Test	–	 test	 formulation	containing	polyherbal	extracts	
(10 µg/kg was administered orally for 8 days).
The experimental protocol was approved by the IAEC (Approval 
No – 17/IAEC/CLPT/2017-18.).
Morris water maze (MWM)
This technique was used to measure learning degree and spatial memory. All 
rats were trained in a standard MWM task. Maze consisted of large circular 
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Fig. 11: FT-IR spectrum of Withania somnifera extract with chitosan
Fig. 12: FT-IR spectrum of Withania somnifera extract with spray dried chitosan
Fig. 13: FT-IR spectrum of final spray-dried formulation
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pool (75 cm and 30 cm) filled with water at a depth of 20 cm. The pool was 
divided into four quadrants. A circular platform was placed at the center 
of one quadrant. The rats performed four trials period for 4 consecutive 
days. In the swimming trials, each individual rat was released gently into 
the water at a randomly chosen quadrant. The rat swam and learned how 
to find the hidden platform within 60 S. After reaching the platform, rat was 
allowed to stay on the platform for 15 S and was then taken back into the 
cage. The rats were placed on the platform by hand for 15 S, if they could 
not escape to the platform within 60 S by themselves, and their escape 
latency was accepted as 60 S. During the intertrial intervals, animals were 
kept in a dry home cage for 60 S. The time to reach the platform latency was 
recorded. 24 h after the last day of training, subjects were tested on a probe 
trial, during which the escape platform was removed and the time spent in 
the correct quadrant was measured for a 60 S trial.
Diazepam-induced amnesia
Diazepam 1 µg/kg intraperitoneal was administered to young rats 
and transfer latency (TL) was noted after 45 min of injection on the 
8th day and after 24 h. Formulation doses and standard donepezil 
hydrochloride (2.5 µg/kg) were administered for successive 8 days. 
After 60 min of administration of the last dose on the 8th day, diazepam 
1 µg/kg intraperitoneal was administered. TL was noted after 45 min 
administration of diazepam and after 24 h.
RESULTS AND DISCUSSION
FT-IR studies
The significant peaks that were present in chitosan were also existed 
in spray-dried chitosan, and similarly, the significant peaks of 
individual extracts and chitosan were present in spectra of physical 
mixtures. Final formulation spectrum showed the characteristic 
peaks of all the three extracts as well as polymer indicating that 
there were no incompatibilities between the extracts of study and the 
excipients [Figs. 2-13].
Inference from various formulations
In the present research study, various formulations are given in Table 1, of 
which formulation-1 to formulation-10 were not successful. Formulation-11 
and 12 were successful and carried out for further investigation.
Particle size
The particle size determination was carried out using Olympus CX 21i 
Biological Microscope. The optical microscopy images are shown in 
Fig. 14. The average minimum radius and average maximum radius of 
each of these products were tabulated [Table 3].
Surface morphology
The SEM pictures of chitosan, spray-dried chitosan, herbal formulation 
by cross-linking and centrifugation, and herbal formulation by spray-
drying method are presented in Fig. 15-18. It can be seen that the 
chitosan particles do not have particular shape or morphology, whereas 
spray-dried chitosan microspheres were spherical with wrinkles on 
their surface. In case of the herbal formulation prepared by cross-
linking and centrifugation method, the formulation parameters induced 
remarkable change in the surface morphology. Herbal formulation that 
is made by spray-drying method, however, generated well-formed 
spherical particles with a smooth surface when compared to normal 
formulation, which generated irregularly shaped particles.
In vivo studies
MWM test
The polyherbal test formulation showed cholinesterase inhibitor 
mechanism at an effective dose of 10 µg/kg against diazepam-induced 
amnesia in rats. The polyherbal formulation showed comparatively 
Table 1: Spray-dried formulations
S. No. Ingredients Quantity taken in each formulation for spray drying
1 2 3 4 5 6 7 8 9 10 11 12
1 Curcumin extract 95% (µg) - - - - - - - - - - 100 100
2 Commiphora mukul dry 
extract (µg) 
- - - - - - - - - - 100 100
3 Withania somnifera dry extract (µg) - - - - - - - - - - 100 100
4 Chitosan (µg) 300 200 200 50 50 250 250 500 500 500 100 100
5 Acetone (ml) 20 20 20 10 20 - - - - - - -
6 Liquid paraffin (ml) - - - 15 - - - - - - - -
7 Span 80 (ml) - - - 0.5 - - - - - - - -
8 Tween 80 (ml) - - - - 0.5 - - - - - - -
9 Sodium sulfate (µg) - - - - - 100 - 100 - - - 100
10 Distilled water (ml) - - - - - 10 - 10 250 - - 10
11 Lactose (g) - - - - - - - - 100 - - -
12 Glutaraldehyde (ml) - - - - - 2 - 2 - - - 2
13 1% acetic acid (ml) 100 100 100 10 20 100 100 250 250 250 100 100
14 Ethyl acetate (ml) - - - - - - - - - - 50 50
Fig. 14: Optical microscopy images of formulations. (a) Chitosan, 






Table 2: The sequence of trials during the study period of 
MWM test
1st day 2nd day 3rd day 4th day
Q1 Q2 Q3 Q4
Q2 Q3 Q4 Q1
Q3 Q4 Q1 Q2
Q4 Q3 Q2 Q1
MWM: Morris water maze
209
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 202-210
 Nadendla et al. 
significant effect and was measured in terms of TL in S (i.e., learning and 
memory activity). TL was recorded after administration of diazepam 
on the 8th day and even after 24 h after the administration, i.e., on the 
9th day, and graphs were plotted according to the results obtained. 
This effect was attributed to its ability to improve the levels of the 
acetylcholine that is decreased in the AD [Table 4].
CONCLUSION
In the present research study, an attempt was made to design and 
develop a novel drug delivery system using herbal medicine to treat 
AD. FT-IR compatibility study was carried out using the selected 
polymer and the herbal extracts (curcumin extract, guggul extract, 
Fig. 15: Scanning electron microscopy image of chitosan
Fig. 16: Scanning electron microscopy image of spray-dried 
chitosan
Fig. 17: Scanning electron microscopy image of normal formulation
Fig. 18: Scanning electron microscopy image of spray-dried 
formulation
Table 3: Particle size analysis
S. No. Product Number of particles Average minimum radius (µm) Average maximum radius (µm)
01 Chitosan 21 12.272 23.681
02 Spray-dried chitosan 26 3.589 8.148
03 Formulation 26 12.924 29.200
04 Spray-dried formulation 26 2.721 7.612
Table 4: Effect of test formulation on diazepam-induced amnesia
S. No. Group Treatment TL (in S)
8th day After 24 h (i.e., 9th day)
1. I Diazepam 53.6±1.208 56.2±1.685
2. II Standard+diazepam 7.8±0.860 3.2±0.663
3. III Test formulation+diazepam 41±1.304 39±2.469
*p-value was found to be 0.0457 using GraphPad Prism 6 software and was statistically significant
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and ashwagandha extract) and a natural polymer chitosan by spray 
drying. The formulation was characterized for particle size analysis 
using Olympus CX 21i Biological Microscope, surface morphology 
using NIKON TS100 Eclipse, and behavioral test by MWM and was 
compared with the formulation that is formulated without employing 
spray-drying technique. From Table 3, it can be stated that the particle 
size varied from 12.27 µm for normal chitosan to 3.59 µm for spray-
dried chitosan. In the same way, the particle of normal formulation 
(12.9 µm) was about 4–5 times larger than that of spray-dried 
formulation (2.7 µm). Significant p value (using GraphPad Prism 6 
software) was shown when the spray-dried test formulation was 
tested using diazepam-induced amnesia method. The TL was 41 
S±1.304 on the 8th day and 39 S±2.47 after 24 h of intraperitoneal 
administration of diazepam for the test group; it was represented 
in Fig. 19. Further research is going onto develop into an inhalation 
dosage form.
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